Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the phenylpyrazole class, with the molecular formula C12H6BrClF4N2O2 and a molecular weight of approximately 401.54 g/mol[1][2][3]. It is primarily used as a research chemical and has not been approved for clinical use in any country[2]. The compound is listed as an experimental drug candidate and appears in chemical databases such as DrugBank (DB03272), PubChem (CID: 448564), and others[1][2][9]. There are no known indications, clinical trials, or approved uses for this molecule. Its mechanism of action, biological targets, pharmacological activity, or therapeutic potential have not been described in publicly available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-Bromo-3-(5'-carboxy-4'-chloro-2'-fluorophenyl)-1-methyl-5-trifluoromethyl-pyrazol.